CSCS

RapidScale, a Cox Business Company, Continues to Expand its Sales Organization by Hiring Talent in the Central Region

Retrieved on: 
Wednesday, May 17, 2023
Cloud, Cox, Great Lakes, Consultant, Great Plains, CSCS, Correa, TBI, Cox Communications, Sales, Midwestern United States

IRVINE, Calif., May 17, 2023 /PRNewswire-PRWeb/ -- RapidScale, a Cox Business company, continues to expand its sales organization by hiring Domingo Correa as a cloud solutions consultant for the great plains region and Eddie Wolfe as a cloud solutions consultant for the great lakes region. Both CSCs will be reporting to Jason Roberts, who has been promoted to senior sales manager for the central region and will be responsible for driving channel sales and partner enablement within their regions.

Key Points: 
  • Domingo Correa and Edward Wolfe join RapidScale as Cloud Solutions Consultants for the Great Plains and the Great Lakes under Jason Roberts, Sr.
  • Sales Manager, Central Region
    IRVINE, Calif., May 17, 2023 /PRNewswire-PRWeb/ -- RapidScale, a Cox Business company, continues to expand its sales organization by hiring Domingo Correa as a cloud solutions consultant for the great plains region and Eddie Wolfe as a cloud solutions consultant for the great lakes region.
  • Both CSCs will be reporting to Jason Roberts, who has been promoted to senior sales manager for the central region and will be responsible for driving channel sales and partner enablement within their regions.
  • "Both Dom and Eddie have the industry knowledge and sales acumen that our partners can leverage to accelerate their businesses.

Saint Xavier University Launches Master of Science in Exercise Science Program

Retrieved on: 
Thursday, April 27, 2023
Steps, CSCS, Communication, Sport, Student, Education, Information technology, Culture, Evidence-based practice, Sister, Physiology, Research, Multimedia, Power, Associate, Marketing, The Sisters of Mercy, U.S. News & World Report, Athlete, Regeneration, Next Step, College of Arts and Sciences, NSCA, CPSS, SXU, MSES, School, Outline of health sciences, Management, Ethics, Catholic Church, Health, Saint Xavier University, Character, News, Nursing, Tutoring, Online shopping, Science, Exercise physiology

CHICAGO, April 27, 2023 /PRNewswire/ -- Beginning in fall 2023, Saint Xavier University (SXU) will offer for the first time a Master of Science in Exercise Science (MSES) degree program.

Key Points: 
  • CHICAGO, April 27, 2023 /PRNewswire/ -- Beginning in fall 2023, Saint Xavier University (SXU) will offer for the first time a Master of Science in Exercise Science (MSES) degree program.
  • Offered in three formats, the program requires 36-39 credit hours, depending on the student's choice of a scholarly final project.
  • Students may choose from three tracks: traditional Master of Science in Exercise Science, Accelerated Master of Science in Exercise Science, or B.S.
  • in Exercise Science Dual-Degree 4+1 program.

ABSTRAX Principal Scientist Dr. Iain Oswald Wins the ElSohly Award for Discovery of "The Gas" Compounds in Cannabis

Retrieved on: 
Wednesday, April 26, 2023
Agricultural Research Organization, Volcani Center, University, CSCS, VSC, Innovation, Research, Mass spectrometry, Doctor of Philosophy, Terpene, Sulfur, Thought, Science Innovation Award, Student, American Chemical Society, Cannabis, Entrepreneurship, Family, Medicinal plants

TUSTIN, Calif., April 26, 2023 /PRNewswire-PRWeb/ -- ABSTRAX is excited to announce that Iain Oswald, PhD, its Principal Research Scientist, has been awarded the prestigious ElSohly Award in Cannabis Chemistry research for the discovery of a new class of volatile sulfur compounds responsible for the characteristic gassy, skunky aroma produced by cannabis. Oswald received the award on March 21 at the National American Chemical Society in Indianapolis via the Cannabis Chemistry Subdivision (CANN).

Key Points: 
  • Oswald received the award on March 21 at the National American Chemical Society in Indianapolis via the Cannabis Chemistry Subdivision (CANN).
  • "We are exceedingly proud of our principal research scientist, Iain, for his shared passion, dedication and hard work," said Max Koby, Co-Founder and CEO of ABSTRAX.
  • The ubiquity and importance of these compounds in cannabis have since led the authors to coin this class of compounds as Cannasulfur Compounds (CSCs).
  • The organization established the ElSohly Award in honor of Dr. Mahmoud ElSohly, a legendary cannabis chemist scientist who has made countless contributions to the field.

Hospitals Focus on Staffing, Supply Chains and Outsourced Service Providers as Priorities Shift Again

Retrieved on: 
Thursday, March 9, 2023
Physician, Hospital, Pharmacy, CSC, L.E.K. Consulting, CSCS, Investment, COVID-19, Nursing, Medtech, Digital health, Retail

BOSTON, March 9, 2023 /PRNewswire/ -- The cascading effects of the pandemic will continue to shape hospital and health system priorities for at least the next several years – and providers said they will look to their outsourced service providers and strategic suppliers for greater support, according to global strategy consultancy L.E.K. Consulting's annual survey of hospital decision-makers.

Key Points: 
  • •Hospitals continue to focus on key operational needs – specifically on staffing and the repercussions of inflation, which have become predominant new priorities.
  • Supply chain cost containment continues to be an area of focus, with renewed emphasis on the strategic importance of the supply chain function.
  • Consolidation continues, albeit at a slower pace as hospitals shift focus back to optimizing their current operations rather than pursuing acquisitions.
  • "To support all of their needs in a more cost-effective manner, hospitals are increasing their utilization of outsourced service providers and strategic suppliers."

Novelis Demonstrates Commitment to Aluminum Beverage Packaging Innovation with Opening of New Can Customer Solution Center

Retrieved on: 
Wednesday, March 8, 2023
Novelis, Container deposit legislation in the United States, Creativity, Energy, Water, CSC, Drink, Wine, Beer, Aluminium, CSCS, Recycling, Senior, Bottled water

The center will focus on advancing aluminum beverage can innovation and sustainability solutions in response to growing market demand.

Key Points: 
  • The center will focus on advancing aluminum beverage can innovation and sustainability solutions in response to growing market demand.
  • Bringing these parties together will inspire ideas and accelerate innovation that will address real-world challenges and advance the adoption of aluminum as the material of choice for beverage packaging.
  • As the largest producer of aluminum sheet for the beverage packaging market and the largest recycler of used beverage cans, Novelis is leading the market through innovation and customer collaboration.
  • As the market grows, the need for sustainable aluminum packaging increases, further driving the need for capacity and innovation.

Raising Confident and Competent Eaters - Free Webinar

Retrieved on: 
Friday, February 17, 2023
Life, Diet, Incessant Visions, Mental disorder, Eating, Obesity, Pediatrics (journal), Transform, Achievement Medal, Body image, FEG, Food, Culture, Mortality, CSCS, Health, National Eating Disorders Association, Parent, AAP, Knowledge, American Academy, Conditional sentence, Wellness, Social media, CDN, Dietary supplement, Birth control, Nursing, Education, RD, The New York Times

GRAND RAPIDS, Mich., Feb. 17, 2023 /PRNewswire/ -- "Unapologetic Eating" author Alissa Rumsey will join Fusion Education Group (FEG) next week for a national webinar focused on raising teens who have healthy relationships with food.

Key Points: 
  • "When we challenge that assertion and learn to trust our own bodies, amazing things unfold," said author Alissa Rumsey.
  • FEG, a national leader in personalized learning, continues its free national webinar series.
  • The webinar information follows:
    Rumsey is the author of Unapologetic Eating: Make Peace with Food and Transform Your Life.
  • FEG hosts monthly webinars free and open to the public to support parents raising middle and high schoolers.

Michael F. Price Memorial Grant from DeGregorio Family Foundation Awarded to Disrupt Cancer Stem Cells with Novel Experimental Drugs

Retrieved on: 
Friday, February 17, 2023
Esophageal cancer, Stomach cancer, De Gregorio, Grant, Patient, CSC, Maintenance, Cell, Metastasis, University, Research, Death, The, WNT, CSCS, Cancer, Doctor of Philosophy, Pharmaceutical industry, Vaccine

The Grant is named in memory of Michael F. Price, the noted value investor and philanthropist, who was an early supporter of the Foundation.

Key Points: 
  • The Grant is named in memory of Michael F. Price, the noted value investor and philanthropist, who was an early supporter of the Foundation.
  • Dr. Capobianco's research is dedicated to targeting cancer stem cell populations by dual inhibition of the Notch and Wnt pathways in upper GI cancers with novel experimental drugs.
  • It is widely accepted that these properties of cancer are driven by distinct populations of cells termed cancer stem cells (CSCs).
  • "We are honored to support this research into ways to destroy the cancer stem cell population in upper GI with novel experimental drugs," concluded Lynn DeGregorio, President and Founder.

Brooks Rehabilitation and University of Utah Researchers Receive $1.6 million Grant to Study Mindfulness in Physical Therapy for Chronic Pain and Opioid Usage

Retrieved on: 
Thursday, February 9, 2023
R01, NCCIH, Doctor of Science, Mogul skiing, Attention, DPT, University, Physician, Drug, Alternative medicine, Patient, Bangladesh Technical Education Board, Thought, NIH, Pain, Rehabilitation, Florida College, Chronic pain, Mindfulness, PT, Therapy, University of Florida College of Public Health and Health Professions, CSCS, Pain management, Anxiety, Physical, Death, National Center for Complementary and Integrative Health, Public health, Exercise, MPH, COVID-19, UF, Doctor of Philosophy, Dentistry, Nursing

ORLANDO, Fla. and JACKSONVILLE, Fla., Feb. 9, 2023 /PRNewswire/ -- One third of adults in the U.S. have chronic musculoskeletal pain. Opioids are commonly prescribed for pain management, however prescription opioids can pose risks of opioid misuse, addiction, overdose and even death. Physical therapy is a non-pharmacological approach that can help mitigate these risks, and researchers from Brooks Rehabilitation and the University of Utah believe mindfulness training could be a key addition to a physical therapist's toolkit.

Key Points: 
  • Physical therapy is a non-pharmacological approach that can help mitigate these risks, and researchers from Brooks Rehabilitation and the University of Utah believe mindfulness training could be a key addition to a physical therapist's toolkit.
  • The grant funds a feasibility study to train physical therapists to use mindfulness-based interventions to manage patients with chronic musculoskeletal pain and long-term opioid use.
  • The three-year, multi-site study, "Physical Therapy Integrated with Mindfulness for Patients with Chronic Musculoskeletal Pain and Long-term Opioid Treatment," combines faculty expertise from the University of Utah and UF with the robust rehabilitation system of Brooks Rehabilitation.
  • Results from the study will further support future projects, including testing the effectiveness of integrating mindfulness in the physical therapy setting.

Hillstream BioPharma to Host Virtual R&D Day to Showcase its Emerging Immuno-oncology Pipeline Targeting Drug-Resistant Cancers

Retrieved on: 
Monday, February 6, 2023
Metastasis, Drug resistance, Epitope, Biotechnology, MD, CSCS, DFCI, Iron, Therapy, Harvard University, Ferroptosis, CDR, Dana–Farber Cancer Institute, H3, CSC, Cell death, Doctor of Philosophy, Vaccine, Management, Pharmaceutical industry, Hillstream loach

BRIDGEWATER, N.J., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing therapeutic candidates targeting drug resistant and devastating cancers using ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death, and immuno-oncology targeted novel biologics, will be hosting a virtual R&D Day on Tuesday, February 14, 2023.

Key Points: 
  • "By targeting ferroptosis, an emerging new anti-cancer mechanism, we’ve seen immensely encouraging progress against drug resistant cancers.”
    HSB-1940 combines a novel anti-PD-1 Picobody™ with long half-life-Quatramers.
  • Hillstream believes it could more efficiently target undruggable epitopes with greater binding affinity than approved biologics.
  • Targeting PD-1 is a step toward enabling Hillstream to enter the rapidly growing Immuno-oncology (IO) therapeutics market with additional IO targets.
  • A replay of Hillstream’s R&D Day can be accessed via Hillstream’s IR site .

Hillstream BioPharma Signs an Exclusive Option Agreement to Advance Next-Generation Anti-MUC1-C Agents for Drug Resistant Cancers

Retrieved on: 
Tuesday, January 31, 2023
Inflammation, CSCS, Cancer, SCLC, MUC1, NEPC, Iron, Ferroptosis, Drug resistance, Dana–Farber Cancer Institute, Hitachi HD44780 LCD controller, TNBC, CSC, Immunosuppression, Cell death, Pharmaceutical industry, Vaccine, Hillstream loach

BRIDGEWATER, N.J., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream”, or the “Company”), a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers, today announced signing an exclusive option agreement with Dana-Farber Cancer Institute to license technology targeting the MUC1-C oncoprotein.

Key Points: 
  • The MUC1 gene was identified by Dr. Donald Kufe, Distinguished Physician and Researcher at Dana-Farber and based on its overexpression in human cancers.
  • Dr. Kufe’s long-standing work has supported the premise that prolonged activation of MUC1-C in settings of chronic inflammation promotes cancer.
  • “We look forward to this unique opportunity to work with Dr. Kufe and Dana-Farber,” said Randy Milby, CEO of Hillstream.
  • “This agreement allows Hillstream to leverage our Quatramer platform to advance anti-MUC1-C agents targeting CSCs for the treatment of highly aggressive tumors, which represents a major unmet need for patients.”